2-polyunsaturated acyl lysophosphatidylethanolamine attenuates inflammatory response in zymosan A-induced peritonitis in mice

Lipids

Volumn 46, Issue 10, 2011, Pages 893-906

  Hung, Nguyen Dang ^a   Kim, Mee Ree ^a   Sok, Dai Eun ^a  

^a Chungnam National University   (South Korea)

Author keywords

2 (15 HETE) lysoPtdEtn; 2 (17 HDHE) lysoPtdEtn; 2 ARA lysoPtdEtn; 2 DHA lysoPtdEtn; Anti inflammatory; Zymosan A

Indexed keywords

1 LYSO 2 ARACHIDONOYL SN GLYCERO 3 PHOSPHOETHANOLAMINE; 1 LYSO 2 DOCOSAHEXAENOYL SN GLYCERO 3 PHOSPHOETHANOLAMINE; 1 LYSO 2 HYDROXY 4,7,10,13,15,19 DOCOSAHEXAENOYL SN GLYCERO 3 PHOSPHOETHANOLAMINE; 1 LYSO 2 HYDROXY 5,8,11,13 EICOSATETRAENOYL SN GLYCERO 3 PHOSPHOETHANOLAMINE; 12 HYDROXYICOSATETRAENOIC ACID; 15 HYDROXYICOSATETRAENOIC ACID; 2 POLYUNSATURATED ACYLLYSOPHOSPHATIDYLETHANOLAMINE; ANTIINFLAMMATORY AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEUKOTRIENE B4; LIPOXIN A; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE; DRUG DOSE INCREASE; LEUKOCYTE MIGRATION; LIPID OXIDATION; LOW DRUG DOSE; MOUSE; NONHUMAN; OXYGENATION; PERITONITIS; TREATMENT RESPONSE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARACHIDONATE 15-LIPOXYGENASE; CYTOKINES; LEUKOCYTES; LIPOXYGENASE INHIBITORS; LYSOPHOSPHOLIPIDS; MICE; MICE, INBRED ICR; OXIDATION-REDUCTION; PERITONITIS; ZYMOSAN;

MUS;

EID: 80054793451     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-011-3589-2     Document Type: Article

References (64)

1. C Nathan 2002 Points of control in inflammation Nature 420 846 852 12490957 10.1038/nature01320 1:CAS:528:DC%2BD38XpsFygtLY%3D (Pubitemid 36019637)
2. DW Gilroy T Lawrence M Perretti AG Rossi 2004 Inflammatory resolution: new opportunities for drug discovery Nat Rev Drug Discov 3 401 416 15136788 10.1038/nrd1383 1:CAS:528:DC%2BD2cXktlCrt7w%3D (Pubitemid 38618123)
3. CN Serhan N Chiang TE Van Dyke 2008 Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators Nat Rev Immunol 8 349 361 18437155 10.1038/nri2294 1:CAS:528:DC%2BD1cXltFejsbw%3D (Pubitemid 351595216)
4. CN Serhan J Savill 2005 Resolution of inflammation: the beginning programs the end Nat Immunol 6 1191 1197 16369558 10.1038/ni1276 1:CAS:528:DC%2BD2MXhtlShur7P (Pubitemid 43045627)
5. CN Serhan R Yang K Martinod K Kasuga PS Pillai TF Porter SF Oh M Spite 2009 Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions J Exp Med 206 15 23 19103881 10.1084/jem.20081880 1:CAS:528:DC%2BD1MXhtVOhtb8%3D
6. G Schmitz K Ruebsaamen 2010 Metabolism and atherogenic disease association of lysophosphatidylcholine Atherosclerosis 208 10 18 19570538 10.1016/j.atherosclerosis.2009.05.029 1:CAS:528:DC%2BC3cXkt1eruw%3D%3D
7. XQ Ye 2008 Lysophospholipid signaling in the function and pathology of the reproductive system Hum Reprod Update 14 519 536 18562325 10.1093/humupd/dmn023 1:CAS:528:DC%2BD1cXhtVSitrfK
8. LS Huang ND Hung DE Sok MR Kim 2010 Lysophosphatidylcholine containing docosahexaenoic acid at the sn-1 position is anti-inflammatory Lipids 45 225 236 20165929 10.1007/s11745-010-3392-5 1:CAS:528:DC%2BC3cXivFemurY%3D
9. ND Hung MR Kim DE Sok 2011 Mechanisms for anti-inflammatory effects of 1-[15(S)-hydroxyeicosapentaenoyl] lysophosphatidylcholine, administered intraperitoneally, in zymosan A-induced peritonitis Br J Pharmacol 162 1119 1135 21091644 10.1111/j.1476-5381.2010.01117.x 1:CAS:528:DC%2BC3MXhslWgs7w%3D
10. K Makide H Kitamura Y Sato M Okutani J Aoki 2009 Emerging lysophospholipid mediators, lysophosphatidylserine, lysophosphatidylthreonine, lysophosphatidylethanolamine and lysophosphatidylglycerol Prostaglandins Other Lipid Mediat 89 135 139 19427394 10.1016/j.prostaglandins.2009.04.009 1:CAS:528:DC%2BD1MXhtV2lu7nM
11. A Sturm J Zeeh T Sudermann H Rath G Gerken AU Dignass 2002 Lisofylline and lysophospholipids ameliorate experimental colitis in rats Digestion 66 23 29 12379812 10.1159/000064418 1:CAS:528:DC%2BD38XnvV2ktL0%3D (Pubitemid 36151287)
12. ND Hung MR Kim DE Sok 2009 Anti-inflammatory action of arachidonoyl lysophosphatidylcholine or 15-hydroperoxy derivative in zymosan A-induced peritonitis Prostaglandins Other Lipid Mediat 90 105 111 19819343 10.1016/j.prostaglandins.2009.10.001 1:CAS:528:DC%2BD1MXhsVaitr3J
13. LS Huang MR Kim DE Sok 2007 Oxygenation of 1-docosahexaenoyl lysophosphatidylcholine by lipoxygenases; conjugated hydroperoxydiene and dihydroxytriene derivatives Lipids 42 981 990 17879105 10.1007/s11745-007-3112-y 1:CAS:528:DC%2BD2sXhtlKqtLbE (Pubitemid 350127312)
14. LS Huang JS Kang MR Kim DE Sok 2008 Oxygenation of arachidonoyl lysophospholipids by lipoxygenases from soybean, porcine leukocyte, or rabbit reticulocyte J Agric Food Chem 56 1224 1232 18247539 10.1021/jf073016i 1:CAS:528:DC%2BD1cXhsVKls7o%3D (Pubitemid 351364051)
15. LS Huang MR Kim DE Sok 2009 Enzymatic reduction of polyunsaturated lysophosphatidylcholine hydroperoxides by glutathione peroxidase-1 Eur J Lipid Sci Tech 111 584 592 10.1002/ejlt.200900023 1:CAS:528:DC%2BD1MXos1aqtrs%3D
16. KE Olofsson L Andersson J Nilsson H Bjorkbacka 2008 Nanomolar concentrations of lysophosphatidylcholine recruit monocytes and induce pro-inflammatory cytokine production in macrophages Biochem Bioph Res Co 370 348 352 10.1016/j.bbrc.2008.03.087 1:CAS:528:DC%2BD1cXlslCqtL8%3D
17. JT Wong K Tran GN Pierce ACOK Chan PC Choy 1998 Lysophosphatidylcholine stimulates the release of arachidonic acid in human endothelial cells J Biol Chem 273 6830 6836 9506985 10.1074/jbc.273.12.6830 1:CAS:528:DyaK1cXitVGhsrY%3D (Pubitemid 28161458)
18. AH Morgan V Dioszeghy BH Maskrey CP Thomas SR Clark SA Mathie CM Lloyd H Kuhn N Topley BC Coles PR Taylor SA Jones VB O'Donnell 2009 Phosphatidylethanolamine-esterified eicosanoids in the mouse tissue localization and inflammation-dependent formation in th-2 disease J Biol Chem 284 21185 21191 19531470 10.1074/jbc.M109.021634 1:CAS:528:DC%2BD1MXpt1Wjurw%3D
19. A Tokumura J Sinomiya S Kishimoto T Tanaka K Kogure T Sugiura K Satouchi K Waku K Fukuzawa 2002 Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids Biochem J 365 617 628 11982483 1:CAS:528:DC%2BD3sXptFOhtbc%3D (Pubitemid 34864443)
20. EG Bligh WJ Dyer 1959 A rapid method of total lipid extraction and purification Can J Biochem Physiol 37 911 917 13671378 10.1139/o59-099 1:CAS:528:DyaG1MXhtVSgt70%3D
21. S Yu M Peng M Ronis T Badger N Fang 2010 Analysis of polar lipids in the serum from rats fed shiitake by liquid chromatography-mass spectrometry/mass spectrometry J Agric Food Chem 58 12650 12656 21090619 10.1021/jf103266c 1:CAS:528:DC%2BC3cXhsVCksLnK
22. RS Byrum JL Goulet JN Snouwaert RJ Griffiths BH Koller 1999 Determination of the contribution of cysteinyl leukotrienes and leukotriene b4 in acute inflammatory responses using 5-lipoxygenase- and leukotriene A4 hydrolase-deficient mice J Immunol 163 6810 6819 10586081 1:CAS:528: DyaK1MXotFShtrs%3D
23. DFP Leite J Echevarria-Lima SC Ferreira JB Calixto VM Rumjanek 2007 Abc transporter inhibition reduces zymosan-induced peritonitis J Leukocyte Biol 82 630 637 17576824 10.1189/jlb.0107042 1:CAS:528:DC%2BD2sXhtValu7vO (Pubitemid 47367155)
24. NL Rao PJ Dunford X Xue X Jiang KA Lundeen F Coles JP Riley KN Williams CA Grice JP Edwards L Karlsson AM Fourie 2007 Anti-inflammatory activity of a potent, selective leukotriene a4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton J Pharmacol Exp Ther 321 1154 1160 17371808 10.1124/jpet.106.115436 1:CAS:528:DC%2BD2sXmsFeqsLo%3D (Pubitemid 46762702)
25. M Arita F Bianchini J Aliberti A Sher N Chiang S Hong R Yang NA Petasis CN Serhan 2005 Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1 J Exp Med 201 713 722 15753205 10.1084/jem.20042031 1:CAS:528:DC%2BD2MXitl2rt74%3D (Pubitemid 40395117)
26. E Kolaczkowska M Barteczko B Plytycz B Arnold 2008 Role of lymphocytes in the course of murine zymosan-induced peritonitis Inflamm Res 57 272 278 18516709 10.1007/s00011-007-7131-1 1:CAS:528:DC%2BD1cXnvFGgt7c%3D
27. YP Sun SF Oh J Uddin R Yang K Gotlinger E Campbell SP Colgan NA Petasis CN Serhan 2007 Resolvin D1 and its aspirin-triggered 17r epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation J Biol Chem 282 9323 9334 17244615 10.1074/jbc.M609212200 1:CAS:528: DC%2BD2sXjtlCisbk%3D (Pubitemid 47104612)
28. G Bannenberg RL Moussignac K Gronert PR Devchand BA Schmidt WJ Guilford JG Bauman B Subramanyam HD Perez JF Parkinson CN Serhan 2004 Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration Brit J Pharmacol 143 43 52 10.1038/sj.bjp.0705912 1:CAS:528:DC%2BD2cXotVenurg%3D (Pubitemid 39280023)
29. SG Jeon HG Moon YS Kim JP Choi TS Shin SW Hong YM Tae SH Kim Z Zhu YS Gho YK Kim 2009 15-lipoxygenase metabolites play an important role in the development of a T-helper type 1 allergic inflammation induced by double-stranded RNA Clin Exp Allergy 39 908 917 19260872 10.1111/j.1365-2222. 2009.03211.x 1:CAS:528:DC%2BD1MXnsF2jsbo%3D
30. KI Yuhki F Ushikubi H Naraba A Ueno H Kato F Kojima S Narumiya Y Sugimoto M Matsushita S Oh-Ishi 2008 Prostaglandin I-2 plays a key role in zymosan-induced mouse pleurisy J Pharmacol Exp Ther 325 601 609 18256172 10.1124/jpet.107.134494 1:CAS:528:DC%2BD1cXlsVOjt7w%3D (Pubitemid 351574802)
31. SP Hui H Chiba S Jin H Nagasaka T Kurosawa 2010 Analyses for phosphatidylcholine hydroperoxides by lc/ms J Chromatogr B 878 1677 1682 10.1016/j.jchromb.2010.04.011 1:CAS:528:DC%2BC3cXmvVWnu7g%3D
32. CN Serhan S Hong K Gronert SP Colgan PR Devchand G Mirick RL Moussignac 2002 Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals J Exp Med 196 1025 1037 12391014 10.1084/jem.20020760 1:CAS:528:DC%2BD38XotFGltLc%3D (Pubitemid 35231761)
33. TJ Guzik R Korbut T Adamek-Guzik 2003 Nitric oxide and superoxide in inflammation and immune regulation J Physiol Pharmacol 54 469 487 14726604 1:CAS:528:DC%2BD2cXnvFCnsA%3D%3D (Pubitemid 38029745)
34. NG Bazan 2009 Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease J Lipid Res 50 Suppl S400 S405 19018037 10.1194/jlr.R800068-JLR200
35. JM Schwab N Chiang M Arita CN Serhan 2007 Resolvin E1 and protectin D1 activate inflammation-resolution programmes Nature 447 869 874 17568749 10.1038/nature05877 1:CAS:528:DC%2BD2sXms1Wjtrc%3D (Pubitemid 46920139)
36. R Medzhitov 2008 Origin and physiological roles of inflammation Nature 454 428 435 18650913 10.1038/nature07201 1:CAS:528:DC%2BD1cXovV2mtbw%3D
37. E Kolaczkowska S Shahzidi R Seljelid N van Rooijen B Plytycz 2002 Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes Inflammation 26 61 71 11989789 10.1023/A:1014837110735 1:CAS:528:DC%2BD38Xjs12mt7s%3D (Pubitemid 34274484)
38. EJ Goetzl JM Woods RR Gorman 1977 Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-l-hydroxy-5,8,10,14-eicosatetraenoic acid J Clin Invest 59 179 183 830662 10.1172/JCI108617 1:CAS:528:DyaE2sXms1antw%3D%3D (Pubitemid 8018054)
39. Kronke G, Katzenbeisser J, Uderhardt S, Zaiss MM, Scholtysek C, Schabbauer G, Zarbock A, Koenders MI, Axmann R, Zwerina J, Baenckler HW, van den Berg W, Voll RE, Kuhn H, Joosten LA, Schett G (2009) 12/15-lipoxygenase counteracts inflammation and tissue damage in arthritis. J Immunol 183(5):3383-3389
40. G Van Assche P Rutgeerts 2005 Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases-I. Immunology and therapeutic potential of antiadhesion molecule therapy in inflammatory bowel disease Am J Physiol-Gastr L 288 G169 G174 (Pubitemid 40129566)
41. MN Ajuebor AM Das L Virag RJ Flower C Szabo M Perretti 1999 Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: Evidence for an inhibitory loop involving endogenous IL-10 J Immunol 162 1685 1691 9973430 1:CAS:528: DyaK1MXhtVWqtLY%3D (Pubitemid 29307046)
42. M Thelen JV Stein 2008 How chemokines invite leukocytes to dance Nat Immunol 9 953 959 18711432 10.1038/ni.f.207 1:CAS:528:DC%2BD1cXhtVSisL7M
43. G Malleo E Mazzon T Genovese R Di Paola R Caminiti E Esposito P Bramanti S Cuzzocrea 2008 Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome Cytokine 41 136 143 18160304 10.1016/j.cyto.2007.11.003 1:CAS:528: DC%2BD1cXhsl2gt74%3D
44. G Woszczek LY Chen S Nagineni JH Shelhamer 2008 Il-10 inhibits cysteinyl leukotriene-induced activation of human monocytes and monocyte-derived dendritic cells J Immunol 180 7597 7603 18490762 1:CAS:528:DC%2BD1cXmtVams7w%3D
45. WJ Brown H Plutner D Drecktrah BL Judson WE Balch 2008 The lysophospholipid acyltransferase antagonist CI-976 inhibits a late step in copii vesicle budding Traffic 9 786 797 18331383 10.1111/j.1600-0854.2008.00711.x 1:CAS:528:DC%2BD1cXlsVSrtbg%3D (Pubitemid 351494307)
46. ME Brezinski CN Serhan 1990 Selective incorporation of (15s)-hydroxyeicosatetraenoic acid in phosphatidylinositol of human neutrophils-agonist-induced deacylation and transformation of stored hydroxyeicosanoids Proc Natl Acad Sci USA 87 6248 6252 2117277 10.1073/pnas.87.16.6248 1:CAS:528:DyaK3cXlvV2mtb8%3D (Pubitemid 20258994)
47. JM Schwab CN Serhan 2006 Lipoxins and new lipid mediators in the resolution of inflammation Curr Opin Pharmacol 6 414 420 16750421 10.1016/j.coph.2006.02.006 1:CAS:528:DC%2BD28XmslGjs7c%3D
48. Spite M, Norling LV, Summers L, Yang R, Cooper D, Petasis NA, Flower RJ, Perretti M, Serhan CN (2009) Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 461(7268):1287-1291
49. C Miller RY Yamaguchi VA Ziboh 1989 Guinea pig epidermis generates putative anti-inflammatory metabolites from fish oil polyunsaturated fatty acids Lipids 24 998 1003 2559281 10.1007/BF02544068 1:CAS:528:DyaK3cXhtFOjtL8%3D (Pubitemid 20027372)
50. SH Wu PY Liao PL Yin YM Zhang L Dong 2009 Elevated expressions of 15-lipoxygenase and lipoxin a(4) in children with acute poststreptococcal glomerulonephritis Am J Pathol 174 115 122 19095947 10.2353/ajpath.2009.080671 1:CAS:528:DC%2BD1MXhslOlu7g%3D
51. JM Nauroth YC Liu M Van Elswyk R Bell EB Hall G Chung LM Arterburn 2010 Docosahexaenoic acid (DHA) and docosapentaenoic acid (DPAN-6) algal oils reduce inflammatory mediators in human peripheral mononuclear cells in vitro and paw edema in vivo Lipids 45 375 384 20364438 10.1007/s11745-010-3406-3 1:CAS:528:DC%2BC3cXls1WnsrY%3D
52. A Gonzalez-Periz A Planaguma K Gronert R Miquel M Lopez-Parra E Titos R Horrillo N Ferre R Deulofeu V Arroyo J Rodes J Claria 2006 Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: Protectin D1 and 17S-hydroxy-DHA FASEB J 20 2537 2539 17056761 10.1096/fj.06-6250fje 1:CAS:528:DC%2BD28Xht1ygu7nO (Pubitemid 44953772)
53. P Maderna C Godson 2009 Lipoxins: revolutionary road Br J Pharmacol 158 947 959 19785661 10.1111/j.1476-5381.2009.00386.x 1:CAS:528:DC%2BD1MXhsVSks7nO
54. JG Filep C Zouki NA Petasis M Hachicha CN Serhan 1999 Anti-inflammatory actions of lipoxin A(4) stable analogs are demonstrable in human whole blood: modulation of leukocyte adhesion molecules and inhibition of neutrophil-endothelial interactions Blood 94 4132 4142 10590058 1:CAS:528:DyaK1MXnvFOjsbs%3D
55. T Takano CB Clish K Gronert N Petasis CN Serhan 1998 Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A(4) and novel lipoxin B-4 stable analogues J Clin Invest 101 819 826 9466977 10.1172/JCI1578 1:CAS:528:DyaK1cXht1Wrtrg%3D (Pubitemid 28096079)
56. K Gronert T Martinsson-Niskanen S Ravasi N Chiang CN Serhan 2001 Selectivity of recombinant human leukotriene D-4, leukotriene B-4, and lipoxin A(4) receptors with aspirin-triggered 15-epi-lxa(4) and regulation of vascular and inflammatory responses Am J Pathol 158 3 9 11141472 10.1016/S0002-9440(10) 63937-5 1:CAS:528:DC%2BD3MXmsFKkug%3D%3D (Pubitemid 32096464)
57. DG Souza CT Fagundes FA Amaral D Cisalpino LP Sousa AT Vieira V Pinho JR Nicoli LQ Vieira IM Fierro MM Teixeira 2007 The required role of endogenously produced lipoxin A4 and annexin-1 for the production of IL-10 and inflammatory hyporesponsiveness in mice J Immunol 179 8533 8543 18056401 1:CAS:528: DC%2BD2sXhtlyit73O
58. CN Serhan 2008 Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators Prostag Leukotr Ess 79 157 163 10.1016/j.plefa.2008.09.012 1:CAS:528:DC%2BD1cXhsVGhtLfO
59. CN Serhan 2007 Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways Annu Rev Immunol 25 101 137 17090225 10.1146/annurev.immunol.25.022106.141647 1:CAS:528:DC%2BD2sXltlagu7w%3D (Pubitemid 46697904)
60. K Matsumoto I Morita H Hibino S Murota 1993 Inhibitory effect of docosahexaenoic acid-containing phospholipids on 5-lipoxygenase in rat basophilic leukemia-cells Prostag Leukotr Ess 49 861 866 10.1016/0952-3278(93) 90211-E 1:CAS:528:DyaK2cXitFegt7c%3D (Pubitemid 23338175)
61. M Tsunomori Y Fujimoto E Muta H Nishida S Sakuma T Fujita 1996 15-hydroperoxyeicosapentaenoic acid inhibits arachidonic acid metabolism in rabbit platelets more potently than eicosapentaenoic acid Bba-Lipid Lipid Met 1300 171 176 10.1016/0005-2760(95)00243-X (Pubitemid 26195819)
62. JJ Moreno 2009 New aspects of the role of hydroxyeicosatetraenoic acids in cell growth and cancer development Biochem Pharmacol 77 1 10 18761324 10.1016/j.bcp.2008.07.033 1:CAS:528:DC%2BD1cXhsVGhurbP
63. SK Chakrabarti BK Cole YS Wen SR Keller JL Nadler 2009 12/15-Lipoxygenase products induce inflammation and impair insulin signaling in 3t3-l1 adipocytes Obesity 17 1657 1663 19521344 10.1038/oby.2009.192 1:CAS:528:DC%2BD1MXhtVKkurbO
64. Y Wen J Gu SK Chakrabarti K Aylor J Marshall Y Takahashi T Yoshimoto JL Nadler 2007 The role of 12/15-lipoxygenase in the expression of interleukin-6 and tumor necrosis factor-alpha in macrophages Endocrinology 148 1313 1322 17170102 10.1210/en.2006-0665 1:CAS:528:DC%2BD2sXitlWnsbk%3D